An attractive hypothesis may be that intratumoral heterogeneity in Ewing sarcoma and differences in EWS::FLI1 activity arise due to distinct cells of origin, or transformation of the same cell of origin but at different developmental time points or contexts. The gene discussed is EWSR1; the disease is Ewing sarcoma.